(Q39730914)

14 September 2017

title

In vivo-in vitro-in silico pharmacokinetic modelling in drug development: current status and future directions (English)

1 reference

14 September 2017

1 reference

1 reference

2

1 reference

14 September 2017

1

Olavi Pelkonen

1 reference

14 September 2017

Hannu Raunio

3

1 reference

14 September 2017

publication date

1 August 2011

1 reference

Clinical Pharmacokinetics

14 September 2017

published in

1 reference

14 September 2017

volume

50

1 reference

14 September 2017

issue

8

1 reference

14 September 2017

page(s)

483-491

1 reference

Evolving molecules using multi-objective optimization: applying to ADME/Tox

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

Application and impact of population pharmacokinetics in the assessment of antiretroviral pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

Innovative methods to study human intestinal drug metabolism in vitro: precision-cut slices compared with ussing chamber preparations.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

Modelling of drug disposition kinetics in in vitro intestinal absorption cell models.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

Mechanistic approaches to volume of distribution predictions: understanding the processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

Prediction of drug metabolism and interactions on the basis of in vitro investigations.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

Methods for predicting in vivo pharmacokinetics using data from in vitro assays

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

Inhibition and induction of human cytochrome P450 enzymes: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

The pivotal role of hepatocytes in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

Impact of hepatic uptake transporters on pharmacokinetics and drug-drug interactions: use of assays and models for decision making in the pharmaceutical industry

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

Xenobiotic transporters: ascribing function from gene knockout and mutation studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

In vitro-in vivo extrapolation of hepatic clearance: biological tools, scaling factors, model assumptions and correct concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

The impact of in vitro binding on in vitro-in vivo extrapolations, projections of metabolic clearance and clinical drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

Methodological uncertainty in quantitative prediction of human hepatic clearance from in vitro experimental systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

In silico pharmacology for drug discovery: applications to targets and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

In silico prediction of ADME and pharmacokinetics. Report of an expert meeting organised by COST B15.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

ADMET in silico modelling: towards prediction paradise?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

From known knowns to known unknowns: predicting in vivo drug metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

Prediction of ADMET Properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

Comprehensive assessment of ADMET risks in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

Recent developments of in silico predictions of intestinal absorption and oral bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: A tale of 'bottom-up' vs 'top-down' recogn

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

State-of-the-art tools for computational site of metabolism predictions: comparative analysis, mechanistical insights, and future applications

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

The challenges of in silico contributions to drug metabolism in lead optimization

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

Predicting the volume of distribution of drugs in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

Assays to predict drug permeation across the blood-brain barrier, and distribution to brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

Development of good modelling practice for physiologically based pharmacokinetic models for use in risk assessment: the first steps

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

Population-based mechanistic prediction of oral drug absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

Characterizing uncertainty and variability in physiologically based pharmacokinetic models: state of the science and needs for research and implementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

Simulation and prediction of in vivo drug metabolism in human populations from in vitro data

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

Model-based drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

The Simcyp population-based ADME simulator

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

Multiscale modeling in drug discovery and development: future opportunities and present challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

An update on metabolism studies using human hepatocytes in primary culture

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11592400-000000000-00000

In vitro-in vivo extrapolation of hepatic clearance involving active uptake: theoretical and experimental aspects

21 January 2018

1 reference

12 December 2020

Whole body physiologically-based pharmacokinetic models: their use in clinical drug development

1 reference

12 December 2020

Cellular models for ADMET predictions and evaluation of drug-drug interactions.

1 reference

12 December 2020

Human cytochromes P450 in the metabolism of drugs: new molecular models of enzyme-substrate interactions

1 reference

12 December 2020

Challenges in the prediction and modeling of oral absorption and bioavailability

1 reference

12 December 2020

Physiologically-based Kinetic Modelling (PBK Modelling): meeting the 3Rs agenda. The report and recommendations of ECVAM Workshop 63

1 reference

12 December 2020

Application of full physiological models for pharmaceutical drug candidate selection and extrapolation of pharmacokinetics to man

1 reference

12 December 2020

10.2165/11592400-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

14 September 2017

1039262718

0 references

1 reference